Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials
Abstract Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various cardiovascular diseases. However, the potential for asthma exacerbation is one of the major adverse effects of beta-blockers. This study aimed to compare the level of risk for an asthma attack...
Guardado en:
Autores principales: | Kuo-Yang Huang, Ping-Tao Tseng, Yi-Cheng Wu, Yu-Kang Tu, Brendon Stubbs, Kuan-Pin Su, Yutaka J. Matsuoka, Chih-Wei Hsu, Ching-Hsiung Lin, Yen-Wen Chen, Pao-Yen Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e6a75dffe6ea4d42929cd2bcbf27e991 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma
por: Hsin-Kuo Ko, et al.
Publicado: (2021) -
Beta-2 adrenergic receptor (ADRB2) gene polymorphisms and the risk of asthma: a meta-analysis of case-control studies.
por: Si-Qiao Liang, et al.
Publicado: (2014) -
Alpha and beta adrenergic receptors modulate keratinocyte migration.
por: Hsin-Ya Yang, et al.
Publicado: (2021) -
Managing Exacerbations in Thunderstorm Asthma: Current Insights
por: Chatelier J, et al.
Publicado: (2021) -
Outdoor air pollution and the onset and exacerbation of asthma
por: Lina Madaniyazi, et al.
Publicado: (2021)